Anthrax Vaccine Distribution Recommendations Approach Completion

Recommendations are nearing completion to aid U.S. authorities in determining the order in which potential victims of an aerosolized anthrax attack receive vaccinations, an advisory body for the Centers for Disease Control and Prevention said on Thursday (see GSN, April 20).

The CDC Immunization Practices Advisory Committee would provide the finished recommendations to U.S. government personnel following an Aug. 20 gathering of participating entities, Raymond Strikas, with the health agency's National Center for Immunization and Respiratory Diseases, said in a report by the Center for Infectious Disease Research and Policy.

The official cited three levels of priority post-attack vaccine recipients: emergency personnel and individuals subjected to the bacteria immediately upon its dispersal; people who could become infected indirectly; and residents as well as others in transit in adjacent regions.

Preparation of the guidelines has been under way for roughly 10 months, and the panel is still seeking responses to the draft plans, Strikas said.

Several million individuals could receive immunity against anthrax through U.S. vaccine holdings following a potential extremist strike involving the bacteria. A number of newer, experimental vaccinations might prove effective through a smaller number of dosages and at less expense (Center for Infectious Disease Research and Policy release, June 21).

June 22, 2012
About

Recommendations are nearing completion to aid U.S. authorities in determining the order in which potential victims of an aerosolized anthrax attack receive vaccinations, an advisory body for the Centers for Disease Control and Prevention said on Thursday.

Countries